LeadIQ logo
Learn more at LeadIQ.com

Insights

Innovative Pipeline Magenta Therapeutics is actively developing a diverse pipeline of drugs focused on improving stem cell transplant safety and efficacy, offering opportunities to collaborate on novel therapeutics or supply chain solutions for clinical trials.

Recent Strategic Mergers The merger with Dianthus Therapeutics signals an aggressive growth strategy and potential expansion into new markets or therapeutic areas, presenting sales prospects in partnership enablement, integration services, or complementary medical technologies.

Funding and Growth With substantial funding of $86 million and leadership in clinical-stage biotech, Magenta is poised for accelerated research and development efforts, creating opportunities to provide specialized lab equipment, research services, or clinical support solutions.

Leadership and Expertise The appointment of experienced executives like Jeffrey Humphrey indicates a strong focus on clinical and regulatory pathways, helping identify opportunities for medical device vendors, regulatory consulting, and CRO partnerships to streamline development.

Market Potential Magenta’s focus on expanding stem cell transplant applications to treat conditions such as blood cancers and autoimmune diseases opens avenues for sales of biological reagents, diagnostic tools, and supportive therapies targeted at the biotech and healthcare sectors.

Magenta Therapeutics Tech Stack

Magenta Therapeutics uses 8 technology products and services including SiteCatalyst, WP Rocket, Drupal, and more. Explore Magenta Therapeutics's tech stack below.

  • SiteCatalyst
    Analytics
  • WP Rocket
    Caching
  • Drupal
    Content Management System
  • Underscore.js
    Javascript Libraries
  • Akamai Bot Manager
    Security
  • X-XSS-Protection
    Security
  • MediaElement.js
    Video Players
  • Acquia Cloud Site Factory
    Web Hosting

Media & News

Magenta Therapeutics's Email Address Formats

Magenta Therapeutics uses at least 1 format(s):
Magenta Therapeutics Email FormatsExamplePercentage
FLast@magentatx.comJDoe@magentatx.com
100%

Frequently Asked Questions

Where is Magenta Therapeutics's headquarters located?

Minus sign iconPlus sign iconMagenta Therapeutics's main headquarters is located at 100 Technology Square Cambridge, Massachusetts 02139 United States. The company has employees across 1 continents, including North America.

What is Magenta Therapeutics's phone number?

Minus sign iconPlus sign icon You can contact Magenta Therapeutics's main corporate office by phone at
+1-857-201-****
. For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Magenta Therapeutics's stock symbol?

Minus sign iconPlus sign iconMagenta Therapeutics is a publicly traded company; the company's stock symbol is DNTH.

What is Magenta Therapeutics's official website and social media links?

Minus sign iconPlus sign iconMagenta Therapeutics's official website is magentatx.com and has social profiles on LinkedInCrunchbase.

What is Magenta Therapeutics's SIC code NAICS code?

Minus sign iconPlus sign iconMagenta Therapeutics's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Magenta Therapeutics have currently?

Minus sign iconPlus sign iconAs of April 2026, Magenta Therapeutics has approximately 2 employees across 1 continents, including North America. Key team members include Vice President Biometrics: J. L.Vice President, Program Leader: S. P.Vp- Head Of Clinical Development: W. S.. Explore Magenta Therapeutics's employee directory with LeadIQ.

What industry does Magenta Therapeutics belong to?

Minus sign iconPlus sign iconMagenta Therapeutics operates in the Biotechnology Research industry.

What technology does Magenta Therapeutics use?

Minus sign iconPlus sign iconMagenta Therapeutics's tech stack includes SiteCatalystWP RocketDrupalUnderscore.jsAkamai Bot ManagerX-XSS-ProtectionMediaElement.jsAcquia Cloud Site Factory.

What is Magenta Therapeutics's email format?

Minus sign iconPlus sign iconMagenta Therapeutics's email format typically follows the pattern of FLast@magentatx.com. Find more Magenta Therapeutics email formats with LeadIQ.

How much funding has Magenta Therapeutics raised to date?

Minus sign iconPlus sign icon As of April 2026, Magenta Therapeutics has raised $86M in funding. The last funding round occurred on May 12, 2021 for $86M.

When was Magenta Therapeutics founded?

Minus sign iconPlus sign iconMagenta Therapeutics was founded in 2016.

Magenta Therapeutics

Biotechnology ResearchMassachusetts, United States2-10 Employees

Magenta Therapeutics is a clinical-stage biotechnology company developing medicines to bring the curative power of stem cell transplant to more patients with blood cancers, genetic diseases and autoimmune diseases. Magenta is combining leadership in stem cell biology and biotherapeutics development with clinical and regulatory expertise, a unique business model and broad networks in the stem cell transplant community to revolutionize immune reset for more patients.

Magenta is based in Cambridge, Mass. For more information, please visit www.magentatx.com.

Follow Magenta on Twitter: @magentatx.

Section iconCompany Overview

Headquarters
100 Technology Square Cambridge, Massachusetts 02139 United States
Phone number
+1-857-201-****
Website
magentatx.com
SIC Code
8733 - Noncommercial Research Organizations
Stock Symbol
DNTH
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2016
Employees
2-10

Section iconMedia & News

Section iconFunding & Financials

  • $86M

    Magenta Therapeutics has raised a total of $86M of funding over 6 rounds. Their latest funding round was raised on May 12, 2021 in the amount of $86M.

Section iconFunding & Financials

  • $86M

    Magenta Therapeutics has raised a total of $86M of funding over 6 rounds. Their latest funding round was raised on May 12, 2021 in the amount of $86M.

Company Leadership

  • Stylized image of a person
    J. L.
    Vice President Biometrics
    Phone icon
    Mobile Phone
  • Stylized image of a person
    S. P.
    Vice President, Program Leader
    Phone icon
    Mobile Phone
  • Stylized image of a person
    W. S.
    Vp- Head Of Clinical Development
    Phone icon
    Mobile Phone
  • Stylized image of a person
    J. A.
    Director, Supply Chain
    Phone icon
    Mobile Phone
  • Stylized image of a person
    L. S.
    Director Corporate Communications
    Phone icon
    Mobile Phone

Employee Directory

  • Stylized image of a person
    C. G.
    Senior Accountant
    Phone icon
    Mobile Phone
  • Stylized image of a person
    K. R.
    Senior Research Associate
    Phone icon
    Mobile Phone
  • Stylized image of a person
    A. M.
    Undefined
    Phone icon
    Mobile Phone
  • Stylized image of a person
    T. A.
    Executive Assistant
    Phone icon
    Mobile Phone
  • Stylized image of a person
    J. S.
    Phone icon
    Mobile Phone

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust LeadIQ to help them build pipeline confidently.

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.